FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2089760007> ?p ?o ?g. }

• W2089760007 endingPage "1540" @default.
• W2089760007 startingPage "1533" @default.
• W2089760007 abstract "A protective or deleterious role of CD8+T cells in human cutaneous leishmaniasis (CL) has been debated. The present report explores the participation of CD8+T cells in disease pathogenesis as well as in parasite killing. CD8+T cells accumulated in CL lesions as suggested by a higher frequency of CD8+CD45RO+T cells and CD8+CLA+T cells compared with peripheral blood mononuclear cells. Upon Leishmania braziliensis restimulation, most of the CD8+T cells from the lesion expressed cytolytic markers, CD107a and granzyme B. Granzyme B expression in CL lesions positively correlated with lesion size and percentage of TUNEL-positive cells. We also observed a significantly higher percentage of TUNEL-positive cells and granzyme B expression in the biopsies of patients showing a more intense necrotic process. Furthermore, coculture of infected macrophages and CD8+T lymphocytes resulted in the release of granzyme B, and the use of granzyme B inhibitor, as well as z-VAD, Fas:Fc, or anti-IFN-γ, had no effect upon parasite killing. However, coculture of infected macrophages with CD4+T cells strongly increased parasite killing, which was completely reversed by anti-IFN-γ. Our results reveal a dichotomy in human CL: CD8+ granzyme B+T cells mediate tissue injury, whereas CD4+IFN-γ+T cells mediate parasite killing. A protective or deleterious role of CD8+T cells in human cutaneous leishmaniasis (CL) has been debated. The present report explores the participation of CD8+T cells in disease pathogenesis as well as in parasite killing. CD8+T cells accumulated in CL lesions as suggested by a higher frequency of CD8+CD45RO+T cells and CD8+CLA+T cells compared with peripheral blood mononuclear cells. Upon Leishmania braziliensis restimulation, most of the CD8+T cells from the lesion expressed cytolytic markers, CD107a and granzyme B. Granzyme B expression in CL lesions positively correlated with lesion size and percentage of TUNEL-positive cells. We also observed a significantly higher percentage of TUNEL-positive cells and granzyme B expression in the biopsies of patients showing a more intense necrotic process. Furthermore, coculture of infected macrophages and CD8+T lymphocytes resulted in the release of granzyme B, and the use of granzyme B inhibitor, as well as z-VAD, Fas:Fc, or anti-IFN-γ, had no effect upon parasite killing. However, coculture of infected macrophages with CD4+T cells strongly increased parasite killing, which was completely reversed by anti-IFN-γ. Our results reveal a dichotomy in human CL: CD8+ granzyme B+T cells mediate tissue injury, whereas CD4+IFN-γ+T cells mediate parasite killing. chemokine (C-C motif) receptor 7 lysosomal-associated membrane protein 1 cutaneous leishmaniasis cutaneous leukocyte–associated antigen peripheral blood mononuclear cells phycoerythrin T-cell helper type 1 N-benzyloxycarbonyl-Val-Ala-Asp(O-Me) fluoromethyl ketone" @default.
• W2089760007 created "2016-06-24" @default.
• W2089760007 creator A5020803015 @default.
• W2089760007 creator A5022829765 @default.
• W2089760007 creator A5023763468 @default.
• W2089760007 creator A5029646107 @default.
• W2089760007 creator A5032749481 @default.
• W2089760007 creator A5053471036 @default.
• W2089760007 creator A5053977529 @default.
• W2089760007 creator A5059191362 @default.
• W2089760007 creator A5059229632 @default.
• W2089760007 creator A5060376480 @default.
• W2089760007 creator A5061188770 @default.
• W2089760007 creator A5084545243 @default.
• W2089760007 creator A5085801818 @default.
• W2089760007 date "2013-06-01" @default.
• W2089760007 modified "2023-10-18" @default.
• W2089760007 title "CD8+ Granzyme B+–Mediated Tissue Injury vs. CD4+IFNγ+–Mediated Parasite Killing in Human Cutaneous Leishmaniasis" @default.
• W2089760007 cites W1498831278 @default.
• W2089760007 cites W1518946901 @default.
• W2089760007 cites W1639235773 @default.
• W2089760007 cites W1666173184 @default.
• W2089760007 cites W1965054845 @default.
• W2089760007 cites W1967684158 @default.
• W2089760007 cites W1976522244 @default.
• W2089760007 cites W1978511113 @default.
• W2089760007 cites W1983962010 @default.
• W2089760007 cites W2003948064 @default.
• W2089760007 cites W2007824068 @default.
• W2089760007 cites W2022059441 @default.
• W2089760007 cites W2031046183 @default.
• W2089760007 cites W2037717220 @default.
• W2089760007 cites W2039316360 @default.
• W2089760007 cites W2050772005 @default.
• W2089760007 cites W2090682962 @default.
• W2089760007 cites W2105736351 @default.
• W2089760007 cites W2110498124 @default.
• W2089760007 cites W2111057638 @default.
• W2089760007 cites W2118008929 @default.
• W2089760007 cites W2121771448 @default.
• W2089760007 cites W2141371144 @default.
• W2089760007 cites W2141565267 @default.
• W2089760007 cites W2151770702 @default.
• W2089760007 cites W2153254832 @default.
• W2089760007 cites W2156686268 @default.
• W2089760007 cites W2157796662 @default.
• W2089760007 cites W2162412478 @default.
• W2089760007 cites W2162680854 @default.
• W2089760007 doi "https://doi.org/10.1038/jid.2013.4" @default.
• W2089760007 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3667352" @default.
• W2089760007 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23321919" @default.
• W2089760007 hasPublicationYear "2013" @default.
• W2089760007 type Work @default.
• W2089760007 sameAs 2089760007 @default.
• W2089760007 citedByCount "109" @default.
• W2089760007 countsByYear W20897600072012 @default.
• W2089760007 countsByYear W20897600072013 @default.
• W2089760007 countsByYear W20897600072014 @default.
• W2089760007 countsByYear W20897600072015 @default.
• W2089760007 countsByYear W20897600072016 @default.
• W2089760007 countsByYear W20897600072017 @default.
• W2089760007 countsByYear W20897600072018 @default.
• W2089760007 countsByYear W20897600072019 @default.
• W2089760007 countsByYear W20897600072020 @default.
• W2089760007 countsByYear W20897600072021 @default.
• W2089760007 countsByYear W20897600072022 @default.
• W2089760007 countsByYear W20897600072023 @default.
• W2089760007 crossrefType "journal-article" @default.
• W2089760007 hasAuthorship W2089760007A5020803015 @default.
• W2089760007 hasAuthorship W2089760007A5022829765 @default.
• W2089760007 hasAuthorship W2089760007A5023763468 @default.
• W2089760007 hasAuthorship W2089760007A5029646107 @default.
• W2089760007 hasAuthorship W2089760007A5032749481 @default.
• W2089760007 hasAuthorship W2089760007A5053471036 @default.
• W2089760007 hasAuthorship W2089760007A5053977529 @default.
• W2089760007 hasAuthorship W2089760007A5059191362 @default.
• W2089760007 hasAuthorship W2089760007A5059229632 @default.
• W2089760007 hasAuthorship W2089760007A5060376480 @default.
• W2089760007 hasAuthorship W2089760007A5061188770 @default.
• W2089760007 hasAuthorship W2089760007A5084545243 @default.
• W2089760007 hasAuthorship W2089760007A5085801818 @default.
• W2089760007 hasBestOaLocation W20897600071 @default.
• W2089760007 hasConcept C129374314 @default.
• W2089760007 hasConcept C153911025 @default.
• W2089760007 hasConcept C154317977 @default.
• W2089760007 hasConcept C167672396 @default.
• W2089760007 hasConcept C183193105 @default.
• W2089760007 hasConcept C202751555 @default.
• W2089760007 hasConcept C203014093 @default.
• W2089760007 hasConcept C2776062744 @default.
• W2089760007 hasConcept C2779968557 @default.
• W2089760007 hasConcept C2780380082 @default.
• W2089760007 hasConcept C55493867 @default.
• W2089760007 hasConcept C86803240 @default.
• W2089760007 hasConcept C8891405 @default.
• W2089760007 hasConceptScore W2089760007C129374314 @default.
• W2089760007 hasConceptScore W2089760007C153911025 @default.
• W2089760007 hasConceptScore W2089760007C154317977 @default.

• next